BC Environmental and Occupational Health Research Network

Expressions of interest are sought from investigators interested in identifying and further developing, in pre-clinical models, novel antigen specific therapies for treatment of recent onset T1D. The clinical translation potential of the investigations should be emphasized. Of particular interest are also mechanistic studies conducted in collaboration with ongoing antigen-specific T1D clinical trials aiming to correlate blood markers and T cell responses with clinical outcome, glycemic control, and response to therapy. Projects involving close cooperation between clinical results and pre-clinical models to allow for targeted prediction of optimal biomarkers are also deemed of high interest.